• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX INC. AFX; BIFURCATED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX INC. AFX; BIFURCATED Back to Search Results
Model Number BA28-90/I16-30
Device Problems Partial Blockage (1065); Hole In Material (1293); Kinked (1339); Leak/Splash (1354); Migration or Expulsion of Device (1395); Occlusion Within Device (1423)
Patient Problems Failure of Implant (1924); Thrombus (2101)
Event Date 11/15/2016
Event Type  Injury  
Manufacturer Narrative
The devices involved in the event will not be returned for evaluation, they remain implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event Description
It was reported the patient had an initial procedure on (b)(6) 2012 with a bifurcated stent and two infrarenal aortic extensions.On (b)(6) 2016, a follow up computed tomography (ct) done on (b)(6) 2016 showed a potential type 3b endoleak.The physician elected to reline the initial stents with an ovation device.There have been no additional adverse events reported for this patient.
 
Manufacturer Narrative
At the completion of the complaint investigation, based on the information received, the clinical evaluation was able to confirm a type 3b endoleak.Additionally there was evidence to support the following observations; at implant an occlusion of the left iliac artery due to a kinked left iliac stent, the placement of two non-endologix stent to restore patency, proximal cuff migration, intra-stent mural thrombus, main body stent dilation, and insufficient distal stent overlap.The clinical evaluation additionally observed the following potential contributing factors; cuff migration, and intra-stent thrombus.The manufacturing evaluation did not reveal any issues or deviations that would explain the reported event.The manufacturing lot evaluation confirmed all devices met specifications prior to release.The event devices remain implanted in the patient and were unavailable for further evaluation.The root cause of the reported event is unknown.There is not enough information to determine the root cause at this time.There have been no additional adverse events reported for this patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
BIFURCATED
Manufacturer (Section D)
ENDOLOGIX INC.
2 musick
irvine CA 92618
Manufacturer Contact
tahereh sedighi
2 musick
irvine, CA 92618
9495984671
MDR Report Key6216906
MDR Text Key63687918
Report Number2031527-2016-00600
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/23/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2013
Device Model NumberBA28-90/I16-30
Device Lot Number1032593-001
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/01/2016
Initial Date FDA Received12/31/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received03/17/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/04/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
AORTO UNI-ILIAC [INFRARENAL]- 1029457-010; AORTO UNI-ILIAC [INFRARENAL]- 1032596-018
Patient Outcome(s) Required Intervention;
Patient Age76 YR
-
-